ArticleThe Canadian veterinary journal = La revue veterinaire canadienne2026
Prognostic role of pretreatment hematologic values and albumin-globulin ratio in canine appendicular osteosarcoma.
Article in The Canadian veterinary journal = La revue veterinaire canadienne, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Pretreatment inflammatory indices are established negative prognostic factors for survival in human osteosarcoma (OSA). However, studies investigating these values in canine malignancies, specifically canine appendicular OSA, are limited. The prognostic significance of pretreatment inflammatory indices in canine appendicular OSA was investigated in this retrospective study. Animals and procedure: Medical records for dogs with appendicular OSA treated with amputation and adjuvant carboplatin were retrospectively reviewed. The following pretreatment values were evaluated for prognostic significance for progression-free survival (PFS) and disease-specific survival (DSS): serum alkaline phosphatase, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, and albumin-to-globulin ratio. Effects of proximal humeral location, presence of metastasis at diagnosis, and use of rescue chemotherapy on prognosis were also analyzed. Results: Elevated albumin-to-globulin ratio was prognostic for PFS and DSS on univariate analysis but did not retain significance on multivariate analysis. On multivariate analysis, metastasis at diagnosis, elevated serum alkaline phosphatase, and administration of rescue chemotherapy were significantly associated with shorter PFS; whereas metastasis at diagnosis was significantly associated with DSS. Conclusion and clinical relevance: Despite pretreatment inflammatory indices being independently associated with prognosis in human OSA, these values were not associated with either PFS or DSS in this study. Prospective investigation with a larger, standardized cohort is needed to further evaluate the prognostic role of pretreatment inflammatory indices in canine OSA.
Indexed as
Identifiers
41847494PMC12990003What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.